ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
76,42
3,11
(4,24%)
Fermé 14 Janvier 10:00PM
77,00
0,58
( 0,76% )
Avant marché: 3:06PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
77,00
Prix Achat
76,66
Prix Vente
77,22
Volume échangé
1 274
0,00 Fourchette du Jour 0,00
61,16 Plage de 52 semaines 85,57
Cap du marché
Clôture Veille
76,42
Ouverture
-
Dernière Transaction
20
@
77.13
Dernière heure de transaction
15:01:05
Volume financier
-
VWAP
-
Volume moyen (3 m)
892 371
Actions en circulation
158 891 800
Rendement du Dividende
0.42%
Ratio Cours sur Bénéfices
72,23
Bénéfice par action (BPA)
1,06
Chiffre d'affairess
1,16B
Bénéfice net
168,11M

À propos de Bio Techne Corporation

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment make... Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Siège social
Minneapolis, Minnesota, USA
Fondé
-
Bio Techne Corporation est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker TECH. Le dernier cours de clôture d'Bio Techne était de US$76,42. Au cours de la dernière année, les actions de Bio Techne ont été négociées dans une fourchette de prix de US$ 61,16 à US$ 85,57.

Bio Techne compte actuellement 158 891 800 actions en circulation. La capitalisation boursière d'Bio Techne est de US$12,14 milliard. Bio Techne a un ratio cours/bénéfice (ratio PE) de 72.23.

TECH Dernières nouvelles

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine PR Newswire MINNEAPOLIS, Jan. 10, 2025 MINNEAPOLIS, Jan. 10, 2025...

ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics

ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics PR Newswire ST. PAUL, Minn., Jan. 8, 2025 ST. PAUL, Minn., Jan. 8, 2025 /PRNewswire/ -- ScaleReady, in...

BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC

BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC PR Newswire MINNEAPOLIS, Jan. 7, 2025 MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, Dec. 20, 2024 MINNEAPOLIS, Dec. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH...

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT PR Newswire MINNEAPOLIS, Dec. 19, 2024 MINNEAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Bio-Techne...

ScaleReady awards a G-Rex® Grant to Moonlight Bio

ScaleReady awards a G-Rex® Grant to Moonlight Bio PR Newswire ST. PAUL, Minn., Dec. 18, 2024 ST. PAUL, Minn., Dec. 18, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf...

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY PR Newswire MINNEAPOLIS, Dec. 12, 2024 MINNEAPOLIS, Dec. 12, 2024 /PRNewswire/...

BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY

BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY PR Newswire MINNEAPOLIS, Dec. 10, 2024 Company will showcase new assay at the upcoming San Antonio Breast Cancer Symposium MINNEAPOLIS, Dec. 10...

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE PR Newswire MINNEAPOLIS, Nov. 27, 2024 MINNEAPOLIS, Nov. 27, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
11.982.6392961876875.0278.472.522284454275.04557721CS
41.12251.4793581760175.877578.469.4872946873.4384126CS
127.0610.094366599969.9479.8665.6189237173.00090082CS
26-0.2-0.25906735751377.283.6265.6187609974.2352942CS
525.858.2220660576271.1585.5761.1698469273.24387491CS
156-22-22.222222222299113.80551.7978098575.82899568CS
26022.852542.204164550554.1475135.962538.792555401078.03081332CS

TECH - Frequently Asked Questions (FAQ)

What is the current Bio Techne share price?
The current share price of Bio Techne is US$ 77,00
How many Bio Techne shares are in issue?
Bio Techne has 158 891 800 shares in issue
What is the market cap of Bio Techne?
The market capitalisation of Bio Techne is USD 12,14B
What is the 1 year trading range for Bio Techne share price?
Bio Techne has traded in the range of US$ 61,16 to US$ 85,57 during the past year
What is the PE ratio of Bio Techne?
The price to earnings ratio of Bio Techne is 72,23
What is the cash to sales ratio of Bio Techne?
The cash to sales ratio of Bio Techne is 10,48
What is the reporting currency for Bio Techne?
Bio Techne reports financial results in USD
What is the latest annual turnover for Bio Techne?
The latest annual turnover of Bio Techne is USD 1,16B
What is the latest annual profit for Bio Techne?
The latest annual profit of Bio Techne is USD 168,11M
What is the registered address of Bio Techne?
The registered address for Bio Techne is 614 MCKINLEY PLACE N.E, MINNEAPOLIS, MINNESOTA, 55413
What is the Bio Techne website address?
The website address for Bio Techne is www.bio-techne.com
Which industry sector does Bio Techne operate in?
Bio Techne operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NMHINatures Miracle Holding Inc
US$ 2,73
(141,59%)
51,53M
AIFFFirefly Neuroscience Inc
US$ 4,01
(111,05%)
34,01M
HEESH and E Equipment Services Inc
US$ 90,71
(106,44%)
859,33k
ERNAEterna Therapeutics Inc
US$ 0,5053
(63,53%)
38,77M
QETAQuetta Acquisition Corporation
US$ 16,77
(58,96%)
7
PHIOPhio Pharmaceuticals Corporation
US$ 3,80
(-42,42%)
3,06M
NESRNational Energy Services Reunited Corporation
US$ 5,01
(-41,95%)
1
CCECCapital Clean Energy Carriers Corporation
US$ 11,01
(-40,15%)
15
BSBKBogota Financial Corporation
US$ 5,11
(-34,91%)
3
MBIOMustang Bio Inc
US$ 0,1525
(-31,89%)
2,81M
PIIIP3 Partners Inc
US$ 0,2766
(28,71%)
52,17M
NMHINatures Miracle Holding Inc
US$ 2,73
(141,59%)
51,53M
ERNAEterna Therapeutics Inc
US$ 0,5053
(63,53%)
38,77M
AIFFFirefly Neuroscience Inc
US$ 4,01
(111,05%)
34,01M
LAESSEALSQ Corporation
US$ 3,4212
(2,13%)
28,58M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock